Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19
Clara Health

Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study

Sponsored by Duke University

The HERO Registry provides a resource for collecting information on Healthcare Workers (HCWs) currently working in the United States. The overall goal of the Registry is to create and engage a community of HCWs who may be eligible for participation in future research studies, including those of COVID-19 prophylaxis and treatment.

The Hero registry will create a repository of health care workers that can be eligible for future research studies.


Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

The main objectives of the study are, 1) create a virtual community of adult HCWs in the United States, 2) Identify HCWs interested in engaging in upcoming research studies, including those related to COVID-19, and 3) Create a dataset of health related measurements, risk factors, and outcomes for future analysis.

Study type: Observational [Patient Registry] Estimated Enrollment: 100000 participants Actual Study Start Date: April 10, 2020 Estimated Study Completion Date: December 31, 2099

Who is this study for?

The HERO Registry will include HCWs currently working across the United States. For the purposes of this study, a "healthcare worker" is defined as an individual who currently works in a setting where individuals receive healthcare.

Note: individuals do not have to work directly with patients, but may have any role within a setting where individuals receive healthcare, such as housekeeping, food service, etc.

What should I expect?

There is no direct benefit to the participants for their participation in this study, but the information obtained will be used in scientific research and may be helpful to the participant or others in the future. Participants may experience indirect benefits such as learning about their own health, access to health data, and opportunities to participate in future research.

Connect with the study team

Thank you for your interest in advancing COVID-19 treatments.

Please fill out this contact form to be connected to a member of the study team. The following information that you enter will only be authorized to be shared with the research team conducting this specific study.

If you have any difficulties or questions, please contact our support specialists at [email protected]

Have a question?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you’ll be connected to the study team.